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 Background: Congenital cystic adenomatoid malformation (CCAM) and bronchopul-
monary sequestration (BPS) are major embryonic pulmonary developmental anom-
alies. Early surgical excision is becoming an increasingly common option. We 
investigated the clinical features and management of patients with CCAM and BPS 
at the National Taiwan University Hospital. 
 Methods: We conducted a retrospective review of neonates diagnosed with CCAM 
and/or BPS at the Hospital from July 1995 to January 2008. Prenatal examination, 
postnatal presentation, management and patient outcome were analyzed. We also 
propose a concise algorithm for the practical management of these conditions. 
 Results: Sixteen patients were recruited including eight (50%) with CCAM, five (31%) 
with BPS and three (19%) with mixed-type lesions (CCAM with BPS). Thirteen (81%) 
patients were diagnosed antenatally at a median gestational age of 20 weeks. Eleven 
(69%) patients underwent surgical resection before 6 months of age because of respira-
tory distress or repeated pulmonary infection. There were no surgery-related compli-
cations among the seven patients who underwent early surgery within 1 month of age. 
Five (31%) patients remained asymptomatic and did not undergo surgery. All patients 
survived with no limitations to daily activity during follow-up periods of 1−8 years. 
 Conclusion: The high proportion of mixed-type lesions suggests that CCAM and BPS 
may share the same developmental ancestry. Early surgical resection within 1 month 
of age is safe in symptomatic patients. 
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1.  Introduction 
 Congenital cystic adenomatoid malformations 
(CCAM) and bronchopulmonary sequestration (BPS) 
are major categories of congenital pulmonary mal-
formations. CCAM is considered to represent a 
hamartomatous change in the tertiary bronchioles, 
and has an incidence of 1 in 25,000 to 35,000 live 
births. 1,2 BPS has an estimated incidence of 0.15%−
1.7% in the general population 3 and is defined as a 
region of lung parenchyma that lacks a normal con-
nection to the tracheobronchial tree and possesses 
an anomalous systemic blood supply. Advances in 
antenatal ultrasonography mean that most cases 
are now diagnosed prenatally. 4 It is also possible to 
observe their diverse natural courses  in utero , 
from severe hydrops fetalis to total regression. Recent 
studies have focused on the origin and pathogene-
sis of CCAM and BPS, emphasizing the developmen-
tal anomalies occurring in embryonic pulmonary 
bud formation. The occurrence of hybrid CCAM/
BPS lesions revealed by histopathology suggest 
the existence of a common origin for CCAM and 
BPS. 5 
 In the present study, we reviewed our experience 
of neonates with CCAM and BPS. We also empha-
size their management and outcome, and propose 
an algorithm to guide the practical management 
of these conditions. 
2.  Materials and Methods 
 We retrospectively reviewed the medical records of 
neonates diagnosed with CCAM and/or BPS at the 
National Taiwan University Hospital from July 1995 
to January 2008. The institutional review board at 
the Hospital gave approval for this review. The diag-
nosis was based on clinical manifestations, abnor-
mal imaging findings and pathologic confirmation. 
All patients underwent serial fetal ultrasonography 
and postnatal chest radiography (CXR) examina-
tions. Computed tomography (CT) scans and mag-
netic resonance imaging were performed in 13 and 
3 patients respectively. A definite diagnosis could 
only be achieved by histopathology in patients who 
had undergone pulmonary resection. 
 The histopathologic definition of CCAM is based 
on Stocker’s classification: type I (single or multi-
ple cysts of  > 1 cm in diameter, lined by ciliated 
columnar or pseudostratified epithelium, mucus-
secreting cells and prominent cartilage); type II 
(multiple cysts of  < 1 cm in diameter, lined by cy-
lindrical to cuboidal epithelium with prominent 
smooth or striated muscle); and type III (grossly 
solid, histologically microcystic, lined by cuboidal 
epithelium, often intricately folded). 6 BPS is 
described as an ectopic and nonfunctioning pulmo-
nary tissue with its own blood supply, derived ei-
ther from the systemic or pulmonary artery. It may 
be composed of different types of lung tissues in-
cluding bronchi, alveoli, cartilage or ciliated co-
lumnar epithelium. 7 A hybrid lesion is a congenital 
pulmonary malformation manifesting the his-
topathologic features of both CCAM and BPS. 
 Data collected from patients’ medical records 
included sex, gestational age, birth weight, clini-
cal features, findings from antenatal ultrasonogra-
phy and postnatal imaging, management strategies, 
and outcomes. Statistical data are presented as 
median (range) and were compared using Mann-
Whitney  U tests. A  p value  < 0.05 was considered 
significant. 
3.  Results 
3.1.  Patient characteristics and antenatal 
courses 
 Sixteen patients (13 males and 3 females) with the 
diagnosis of CCAM and/or BPS were identified dur-
ing the study period. The median gestational age 
was 38 weeks (32−41 weeks) and the median birth 
weight was 3189 g (1766−4090 g). No patient had any 
other congenital anomalies or hereditary genetic 
disorders. One case was a preterm infant and an-
other case was a small-for-gestational-age infant, 
with a birth weight below the fifth percentile of the 
Taiwanese birth weight curve. 8 There were eight 
patients (50%) with CCAM, five (31%) with BPS and 
three (19%) with hybrid lesions (Table 1). Three 
(38%) patients had type I CCAM and five (62%) pa-
tients had type II CCAM (62%). Three (60%) patients 
had intralobular BPS and two (40%) had extralobu-
lar BPS. The hybrid lesions were often composed 
of type II CCAM and intralobular BPS. The abnormal 
lung lesions were mainly located in the left lower 
lung (8/19, 42%) and the right lower lung (6/19, 
32%), followed by the right upper lung (2/19, 11%), 
the left upper lung (1/19, 5%), the right medial lung 
(1/19, 5%) and the mediastinum (1/19, 5%). 
 Prenatal diagnoses were made in 13 cases (81%) 
at a median gestational age of 20 weeks (20−24 
weeks), while the remaining cases were diagnosed 
within the first postnatal week. The most common 
sonographic finding was macrocystic or microcystic 
fetal lung lesion. Serial antenatal sonographic moni-
toring showed regression of fetal lung lesions in 11 
cases (85%), stable lesions in one case (7.5%) and pro-
gression in one case (7.5%). No pregnancy-related 
complications such as hydrops fetalis, polyhydram-
nios, fetal ascites or fetal pleural effusion were 
noted among the patients. 
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 3.2.  Postnatal clinical features and 
investigations 
 Seven patients had respiratory distress immediately 
after birth. They were subsequently diagnosed with 
CCAM (4 cases), BPS (2 cases) and hybrid lesion (1 
case). Another patient with initially asymptomatic 
CCAM developed dyspnea and mediastinal shift 
after an episode of acute bronchiolitis at 5 months 
of age. We routinely performed CXR and CT (or MRI) 
in patients with fetal lung lesions, even in those 
with regression and normoechoic changes. All an-
tenatally regressed lesions remained abnormal at 
postnatal CT scan. Table 2 shows the common ra-
diologic finding of CCAM and/or BPS. CXR was not 
a sensitive diagnostic tool, and almost 20% of le-
sions were unidentified by this technique. CT and 
MRI are standard diagnostic tools which also delin-
eate aberrant vessels. CCAM usually presented as a 
cystic or hyper-inflated lesion on CXR, and a multi-
cystic/solid lesion on CT scan. BPS always presented 
as a solid mass in the basal lung region and appeared 
as a wedge-shape lesion with aberrant vessels on 
CT scan. Hybrid lesions combined characteristics of 
both CCAM and BPS. It should be diagnosed more 
carefully on a histopathological basis. 
3.3.  Management 
 Surgical resection was performed in seven (88%) 
symptomatic and four (50%) asymptomatic patients. 
Timing of surgery in symptomatic patients was pri-
marily based on the severity of respiratory distress 
and episodes of infection. The median age at surgery 
was 11 days (5−169 days). Ten patients underwent 
thoracotomy, while one underwent video-assisted 
thoracic surgery. Surgical methods included lobec-
tomy ( n = 8) and sequestrectomy ( n = 3). Definite his-
topathologic diagnosis was achieved after surgical 
resection. 
 For further analysis, patients who underwent 
surgery were subdivided into two groups: Group I 
Table 1  Demographic data of 16 neonates with congenital cystic adenomatoid malformation (CCAM), bronchopul-
monary sequestration (BPS) and hybrid lesions
 CCAM ( n = 8) BPS ( n = 5) Hybrid lesion  ( n = 3)
 Males 7 (88%) 4 (80%) 2 (67%) 
 Gestational age (wk)* 38 (37−40) 39 (32−41) 39 (38−39) 
 Birth body weight (g)* 3193 (2732−4090) 2974 (1766−3590) 3198 (2522−3612) 
 Diagnosed during pregnancy 5 (63%) 5 (100%) 3 (100%) 
 In utero spontaneous regression 4 (50%) 4 (80%) 3 (100%) 
 Distribution 
  RUL  1 (11%)  0 (0%)  1 (25%) 
  RML  0 (0%) 1 (20%)  0 (0%) 
  RLL  4 (45%)  2 (40%) 0 (0%)
  LUL  1 (11%)  0 (0%) 0 (0%) 
  LLL 3 (33%)  2 (40%)  3 (75%) 
  Mediastinum  0 (0%) 1 (20%)  0 (0%) 
 *Data presented as median (range). RUL = right upper lung; RML = right medial lung; RLL = right lower lung; LUL = left upper lung; 
LLL = left lower lung. 
Table  2  Postnatal investigation of patients with congenital cystic adenomatoid malformation (CCAM), broncho-
pulmonary sequestration (BPS) and hybrid lesions*
 CCAM ( n = 8) BPS ( n = 5) Hybrid lesion ( n = 3) 
 Chest radiograph 
  Normal  2 (25%)  1 (20%)  0 (0%) 
  Cystic/hyper-inflated lesion  4 (50%)  0 (0%)  1 (33%) 
  Ill-defined solid shadow  2 (25%)  4 (80%)  2 (67%) 
 CT or MRI 
  Multicystic lesion  6 (75%)  0 (0%)  2 (67%) 
  Wedge-shape lesion  2 (25%) 5 (100%)  3 (100%) 
  Aberrant vessels  0 (0%)  3 (60%)  1 (33%) 
 *Data presented as  n (%). CT = computed tomography; MRI = magnetic resonance imaging. 
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included those who underwent surgery prior to 1 
month of age ( n = 7), and Group II included those 
who underwent surgery after 1 month of age ( n = 4; 
Table 3). Group I patients usually presented with 
dyspnea immediately after birth but rarely devel-
oped infections. Group II patients usually had mild 
or no respiratory distress after birth, but gradually 
developed dyspnea and late infection after 1 month 
of age. There were no surgery-related complica-
tions in any patients, indicating that early surgery 
within 1 month of age was safe. There were no sig-
nificant differences in postoperative ventilator days 
or postoperative intensive care unit stay between 
the two groups. 
3.4.  Outcome and follow-up 
 All patients were regularly followed up in the out-
patient clinic for 1−8 years. All patients underwent 
a rehabilitation program conducted by a respira-
tory therapist and a physical therapist. All patients 
who underwent surgery remained disease-free and 
with no limitations of their daily activities. The 
other five patients who did not receive surgery (2 
CCAM, 2 BPS and 1 hybrid lesion) remained asymp-
tomatic during the follow-up periods. There was 
no malignant transformation in any patient in this 
case series. 
4.  Discussion 
 The fetal respiratory system begins to develop at 
3 weeks of gestational age. Abnormal pulmonary de-
velopment caused by insults to the conducting air-
way, vascular or lymphatic system at different stages 
could result in a heterogeneous group of congenital 
lung malformations. 9 Congenital lung malforma-
tions may be detected early by fetal ultrasonography 
at around 18−20 weeks of gestation. 10 CCAM usu-
ally occurs in the pseudocanalicular stage, while BPS 
develops early in the embryonic stage. However, the 
concept of classification of congenital lung malfor-
mations is currently changing, owing to the detec-
tion of further mixed-type lesions, such as hybrid 
CCAM and BPS lesions. 5 This suggests that these le-
sions share the same developmental origin, and may 
represent two ends of a broad pathologic spectrum. 
There was a high proportion (19%) of hybrid lesions 
in our case series, identified by the coexistence of 
accessory blood vessels from the aorta and his-
topathologic characteristic of CCAM. This finding 
supports the theory of a common origin for CCAM 
and BPS. 
 Serial prenatal sonographic examinations are 
important for helping to determine the prognosis 
and necessity for possible intrauterine treatment 
in patients with CCAM and BPS. Hydrops fetalis in 
patients with CCAM or BPS consistently indicates a 
poor prognosis. 11 The degree of hypoplastic lung in 
a fetus, measured as a ratio  < 0.25 of lung to thorax 
transverse area, also suggests a poor prognosis. 12 
Polyhydramnios and mediastinal shift representing 
a significant mass compression effect are warning 
signs, but are not absolute indicators of a poor prog-
nosis. 1 Although some cystic lesions regress spon-
taneously, they can usually still be identified in 
postnatal radiologic evaluations. Postnatal surgical 
resection is required in up to 45% of lesions with 
late-gestational resolution. 13 Nine (69%) of our pa-
tients with prenatal diagnosis eventually under-
went surgical interventions. 
 The appropriate management of congenital cystic 
lung disease remains a matter for debate. Based on 
our experience and a recent literature review, we 
propose an algorithm for the practical management 
of patients with these conditions (Figure 1). If pre-
natal ultrasonographic screening reveals a suspi-
cious fetal lung lesion, a series of ultrasonographic 
examinations is necessary to evaluate the size, 
content (microcystic, macrocystic or solid) and dis-
tribution of the lesion. Fetal MRI and Doppler ul-
trasonography provide further delineation of the 
systemic feeding vessels in BPS. 11 Fetal therapies 
such as needle aspiration, catheter shunt placement 
and fetal surgical resection can be applied by cen-
ters with expertise, but the effectiveness and the 
risks associated with surgery should be carefully 
considered. 14 Be cause antenatal ultrasonography 
is not a good predictor of eventual histologic findings, 
postnatal re-evaluation using standard CXR, CT or 
MRI scan within a few weeks after birth is strongly 
recommended. 4 We believe that an increasing 
number of cases of congenital cystic lung disease 
 Table 3  Comparison of clinical courses of patients 
undergoing surgery before the age of 1 month 
(Group I) and after the age of 1 month 
(Group II)* 
 Group I Group II 
 p † 
 ( n = 7) ( n = 4)
 Clinical manifestations    
 Dyspnea 5 (71%) 3 (75%) 0.90 
 Mediastinal shift 1 (14%) 1 (25%) 0.67 
 Infection 0 (0%) 2 (50%)  < 0.05 
 Postoperative 1 (0−5) 1 (0−3) 0.92 
ventilator days
 Postoperative ICU 5 (2−12) 6 (2−13) 0.77 
stay (d)
 *Values expressed as  n (%) or median (range);  † Mann-Whitney 
 U test. ICU = intensive care unit. 
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could be identified by advanced prenatal examina-
tions. The majority of these lesions will regress or 
become normoechoic in late pregnancy. However, 
many cases will remain undiagnosed in the absence 
of explicit postnatal imaging studies. Our case se-
ries supports this fact, as eleven patients (11/16, 
69%) were diagnosed during the past 2 years by ad-
vanced prenatal ultrasonography and postnatal CT 
re-evaluation. 
 Two major factors affect the management of con-
genital cystic lung disease after birth: the timing of 
respiratory decompensation and the presence of 
any associated complications. 15 Improvements in 
both thoracic surgery and anesthesia in neonates 
mean that most cystic lesions can now be resected 
with minimal mortality and morbidity. 16 However, 
the optimal timing for surgical intervention may 
vary, depending on the clinical condition. Prompt 
surgical excision is indicated in patients with sig-
nificant respiratory distress; however, conservative 
management for asymptomatic patients remains 
controversial. We observed different clinical mani-
festations in the current series: those with surgery 
before 1 month old presented with marked respi-
ratory distress after birth, whereas the surgical in-
dication shifted to recurrent pulmonary infection 
after 1 month. This difference must be taken into 
account when considering the option of surgery. 
 Initially asymptomatic patients sometimes de-
veloped recurrent pulmonary infection with severe 
respiratory decompensation after the age of 1 month. 
Reduced maternally transmitted immune protec-
tion and exposure to environmental pathogens may 
predispose these infants to respiratory infections. 
Although small asymptomatic lesions can regress, 
there have been an increasing number of reports 
of malignancy associated with CCAM over the last 
decade, which cannot be ignored. These associated 
neoplasms consist mainly of pleuropulmonary blas-
toma in infants and young children, 17 and broncho-
alveolar carcinoma in older children and adults. 18 
In addition, a lower incidence of complications and 
shorter hospital stay have been reported in cases 
who received surgery while they were still asymp-
tomatic. 16 Early surgical resection of asymptomatic 
congenital cystic lung lesions at the age of 3−6 
months is therefore recommended by several large 
centers. 19 − 21 This also allows for compensatory lung 
growth before lung maturation. Although the current 
case series was limited in sample size, results re-
garding the timing of surgery and surgical outcome 
are compatible with those of other study groups. 19− 21 
 In the follow-up of patients with cystic lung dis-
ease, regular chest CT scans are needed to clearly 
define the progression or regression of lesions and 
determine the timing for surgical intervention. In 
addition, regular vaccinations for  Haemophilus in-
fluenza type B and  Streptococcus pneumoniae are 
recommended to avoid life-threatening infections. 
Pulmonary function tests should also be considered 
to investigate the long-term outcome in patients 
who have undergone surgery. These data were unfor-
tunately not available for the patients in the current 
study, and future studies are needed to investigate 
this aspect. 
 In summary, the emergence of mixed-type lesions 
suggests that CCAM and BPS may share the same 
developmental origin. Early surgical resection for 
symptomatic CCAM and BPS within 1 month of age is 
safe. Surgical resection should also be considered 
for asymptomatic patients to prevent possible late 
infection and malignant transformation. 
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